NO303714B1 - Pantoprazolholdige orale administrasjonsformer - Google Patents

Pantoprazolholdige orale administrasjonsformer

Info

Publication number
NO303714B1
NO303714B1 NO934648A NO934648A NO303714B1 NO 303714 B1 NO303714 B1 NO 303714B1 NO 934648 A NO934648 A NO 934648A NO 934648 A NO934648 A NO 934648A NO 303714 B1 NO303714 B1 NO 303714B1
Authority
NO
Norway
Prior art keywords
oral administration
pantoprazole
administration forms
containing oral
consist
Prior art date
Application number
NO934648A
Other languages
English (en)
Norwegian (no)
Other versions
NO934648L (no
NO934648D0 (no
Inventor
Rango Dietrich
Hartmut Ney
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4218617&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO303714(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO934648L publication Critical patent/NO934648L/no
Publication of NO934648D0 publication Critical patent/NO934648D0/no
Publication of NO303714B1 publication Critical patent/NO303714B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO934648A 1991-06-17 1993-12-16 Pantoprazolholdige orale administrasjonsformer NO303714B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH178891 1991-06-17
PCT/EP1992/001341 WO1992022284A1 (de) 1991-06-17 1992-06-13 Pantoprazol enthaltende orale darreichungsformen

Publications (3)

Publication Number Publication Date
NO934648L NO934648L (no) 1993-12-16
NO934648D0 NO934648D0 (no) 1993-12-16
NO303714B1 true NO303714B1 (no) 1998-08-24

Family

ID=4218617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934648A NO303714B1 (no) 1991-06-17 1993-12-16 Pantoprazolholdige orale administrasjonsformer

Country Status (33)

Country Link
US (1) US5997903A (cs)
EP (2) EP0519365A1 (cs)
JP (1) JP3338052B2 (cs)
KR (1) KR100254021B1 (cs)
CN (1) CN1037932C (cs)
AT (1) ATE144416T1 (cs)
AU (1) AU683411B2 (cs)
BG (1) BG61796B1 (cs)
CA (2) CA2524168A1 (cs)
CZ (1) CZ281697B6 (cs)
DE (2) DE59207438D1 (cs)
DK (1) DK0589981T3 (cs)
ES (1) ES2096080T3 (cs)
FI (1) FI101598B (cs)
GR (1) GR3022154T3 (cs)
HR (1) HRP920162B1 (cs)
IE (1) IE77640B1 (cs)
IL (1) IL102096A (cs)
LV (1) LV11982B (cs)
MX (1) MX9202961A (cs)
NO (1) NO303714B1 (cs)
NZ (1) NZ243147A (cs)
PL (1) PL169951B1 (cs)
RO (1) RO117502B1 (cs)
RU (1) RU2089180C1 (cs)
SI (1) SI9200111A (cs)
SK (1) SK278566B6 (cs)
TW (1) TW224429B (cs)
UA (1) UA32525C2 (cs)
WO (1) WO1992022284A1 (cs)
YU (1) YU48263B (cs)
ZA (1) ZA924386B (cs)
ZW (1) ZW9392A1 (cs)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4504000A (en) * 1993-04-27 2000-09-07 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
DE4324014C2 (de) * 1993-07-17 1995-06-08 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung
TW280770B (cs) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
PT723436E (pt) * 1994-07-08 2002-02-28 Astrazeneca Ab Forma de dosagem em comprimidos com unidades multiplas
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
PT854718E (pt) * 1995-09-21 2004-08-31 Pharma Pass Ii Llc Composicao farmaceutica contendo um benzimidazole acido-labil e processo para a sua preparacao
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9702000D0 (sv) * 1997-05-28 1997-05-28 Astra Ab New pharmaceutical formulation
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
IN186245B (cs) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
PT1037607E (pt) * 1997-12-08 2004-07-30 Altana Pharma Ag Nova forma de supositorio compreendendo um composto activo instavel em acido
DK173431B1 (da) 1998-03-20 2000-10-23 Gea Farmaceutisk Fabrik As Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs
CA2298823C (en) 1998-04-20 2011-06-07 Eisai Co., Ltd. Stabilized composition comprising a benzimidazole type compound
JP4127740B2 (ja) * 1998-04-20 2008-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定化したベンズイミダゾール系化合物含有組成物
US6328994B1 (en) 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
DK1105105T3 (da) * 1998-08-12 2006-07-17 Altana Pharma Ag Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
EA005803B1 (ru) 1999-06-07 2005-06-30 Алтана Фарма Аг Новый препарат и форма для введения, включающие неустойчивое в кислой среде действующее вещество
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
ES2168043B1 (es) 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
JP4081273B2 (ja) * 1999-10-20 2008-04-23 エーザイ・アール・アンド・ディー・マネジメント株式会社 ベンズイミダゾール系化合物安定化方法
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
ATE297194T1 (de) * 1999-12-16 2005-06-15 Medinfar Produtos Farmaceutico Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
US7357943B2 (en) * 2000-12-07 2008-04-15 Nycomed Gmbh Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
JP2005508330A (ja) 2001-09-28 2005-03-31 マクニール−ピーピーシー・インコーポレイテッド 充填された部分を備えた複合剤形
US20050163846A1 (en) * 2001-11-21 2005-07-28 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound, and process for producing same
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
CA2518780C (en) * 2003-03-12 2014-05-13 Takeda Pharmaceutical Company Limited Drug composition having active ingredient adhered at high concentration to spherical core
AU2003245033A1 (en) * 2003-05-08 2004-11-26 Podili Khadgapathi An improved and stable pharmaceutical composition containing substituted benzimidazoles and a process for its preparation
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
US20050042277A1 (en) * 2003-07-17 2005-02-24 Irukulla Srinivas Pharmaceutical compositions having a swellable coating
KR20060065632A (ko) * 2003-07-17 2006-06-14 닥터 레디스 래보러토리즈, 인코포레이티드 팽창성 코팅을 갖는 약제학적 조성물
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005025569A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Use of known active ingredients as radical scavengers
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
WO2005034924A1 (en) * 2003-10-14 2005-04-21 Natco Pharma Limited Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
US20050175689A1 (en) * 2003-10-27 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Coated fine particles containing drug for intrabuccally fast disintegrating tablet
AU2004287373A1 (en) * 2003-10-31 2005-05-19 Dexcel Ltd. Stable lansoprazole formulation
WO2005046634A2 (de) * 2003-11-14 2005-05-26 Siegfried Generics International Ag Magensaftresistente verabreichungsform
HU227317B1 (en) * 2003-11-25 2011-03-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Enteric coated tablet containing pantoprazole
CA2548144A1 (en) * 2003-12-09 2005-06-23 Pharmasset, Inc. Dosing methods for .beta.-d-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
US20050249806A1 (en) * 2004-02-10 2005-11-10 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
CZ23090U1 (cs) * 2004-03-25 2011-12-19 Astellas Pharma Inc. Kompozice pevného farmaceutického prípravku solifenacinu nebo jeho soli
WO2005092336A1 (ja) * 2004-03-26 2005-10-06 Eisai R&D Management Co., Ltd. 溶出制御製剤とその製造方法
WO2005107721A2 (en) * 2004-05-07 2005-11-17 Altana Pharma Ag Pharmaceutical dosage form comprising pellets as well as its manufacturing process
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050281876A1 (en) * 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US20060024362A1 (en) * 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1830822A1 (en) * 2004-12-24 2007-09-12 LEK Pharmaceuticals D.D. Stable pharmaceutical composition comprising an active substance in the form of solid solution
CA2591761A1 (en) * 2004-12-27 2006-07-06 Astellas Pharma Inc. Stable particulate pharmaceutical composition of solifenacin or salt thereof
WO2006085335A2 (en) * 2005-01-03 2006-08-17 Lupin Limited Pharmaceutical composition of acid labile substances
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
AR054358A1 (es) * 2005-05-13 2007-06-20 Combino Pharm Sl Formulaciones que contienen pantoprazol libre de acido y sus sales
US7815939B2 (en) * 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
EP1747776A1 (en) * 2005-07-29 2007-01-31 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising granular pantoprazole
WO2007037259A1 (ja) * 2005-09-29 2007-04-05 Eisai R & D Management Co., Ltd. 生体内での崩壊性を向上させたパルス製剤
AU2006299424A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties
US8486450B2 (en) 2005-12-28 2013-07-16 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
EP1973532A1 (en) 2006-01-16 2008-10-01 Jubilant Organosys Limited Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
GB2459393B (en) 2006-10-05 2010-09-08 Santarus Inc Novel capsule formulation for the proton pump inhibitor omeprazole
WO2008062320A2 (en) * 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
NZ578204A (en) 2006-12-22 2012-05-25 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
US8821924B2 (en) 2007-09-14 2014-09-02 Wockhardt Ltd. Rhein or diacerein compositions
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
DE102010052847A1 (de) * 2010-11-29 2012-05-31 Temmler Werke Gmbh Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung
CA2898362C (en) 2013-01-15 2020-09-01 Ironwood Pharmaceuticals, Inc. Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
US20180015118A1 (en) 2015-02-03 2018-01-18 Ironwood Pharmaceuticals, Inc. Methods of treating upper gastrointestinal disorders in ppi refractory gerd
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN108065443B (zh) * 2017-12-30 2020-02-28 厦门金达威维生素有限公司 斥水型双包被微胶囊及其制备方法
CN114569579B (zh) 2020-12-02 2023-10-31 丽珠医药集团股份有限公司 肠溶微丸、其制备方法和包含它的制剂
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JPH0768125B2 (ja) * 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤

Also Published As

Publication number Publication date
CA2109697C (en) 2005-11-22
TW224429B (cs) 1994-06-01
AU683411B2 (en) 1997-11-13
UA32525C2 (uk) 2001-02-15
NO934648L (no) 1993-12-16
RU2089180C1 (ru) 1997-09-10
KR940701256A (ko) 1994-05-28
IE921733A1 (en) 1992-11-18
CA2524168A1 (en) 1992-12-23
SK278566B6 (en) 1997-10-08
NO934648D0 (no) 1993-12-16
ZW9392A1 (en) 1993-02-17
RO117502B1 (ro) 2002-04-30
IL102096A0 (en) 1993-01-14
SK128793A3 (en) 1994-06-08
WO1992022284A1 (de) 1992-12-23
YU57692A (sh) 1995-03-27
AU1974692A (en) 1993-01-12
DK0589981T3 (da) 1997-03-17
FI101598B1 (fi) 1998-07-31
JP3338052B2 (ja) 2002-10-28
EP0519365A1 (de) 1992-12-23
GR3022154T3 (en) 1997-03-31
HRP920162A2 (en) 1996-08-31
CN1067809A (zh) 1993-01-13
DE59207438D1 (de) 1996-11-28
DE4219390A1 (de) 1992-12-24
CZ276493A3 (en) 1994-07-13
BG98286A (bg) 1994-08-30
CA2109697A1 (en) 1992-12-23
EP0589981B1 (de) 1996-10-23
HK1005851A1 (en) 1999-01-29
CN1037932C (zh) 1998-04-08
FI935677L (fi) 1993-12-16
LV11982B (lv) 1998-09-20
IL102096A (en) 1996-06-18
LV11982A (lv) 1998-03-20
SI9200111A (en) 1992-12-31
HRP920162B1 (en) 1998-08-31
YU48263B (sh) 1997-09-30
US5997903A (en) 1999-12-07
NZ243147A (en) 1995-12-21
CZ281697B6 (cs) 1996-12-11
FI935677A0 (fi) 1993-12-16
ES2096080T3 (es) 1997-03-01
EP0589981A1 (de) 1994-04-06
MX9202961A (es) 1993-02-01
FI101598B (fi) 1998-07-31
PL169951B1 (pl) 1996-09-30
ATE144416T1 (de) 1996-11-15
IE77640B1 (en) 1997-12-31
BG61796B1 (bg) 1998-06-30
ZA924386B (en) 1993-02-24
JPH06508118A (ja) 1994-09-14
KR100254021B1 (ko) 2000-05-01

Similar Documents

Publication Publication Date Title
DK0589981T3 (da) Pantoprazolholdige orale administrationsformer
FI920523L (fi) Analgetiska kompositioner.
FI885122A0 (fi) Oral komposition innehaollande partiklar som omfattar ett aktivt aemne.
FI942713L (fi) Suun hajujen vähentämiseen tarkoitettuja oraalisia koostumuksia
FI922647A7 (fi) Hoegt hyllager att placera och haolla rullformigt gods, speciellt pappersrullar, i lager omfattande parvis anordnade skenor foer lagring av pappersrullarna
FI923131L (fi) Foerfarande foer hydrogenering av glycerol
DE68901492D1 (de) Orale zusammensetzungen.
DE69007080D1 (de) Orale Hygienezusammensetzung.
DE68902629D1 (de) Orale zusammensetzung.
FI911009L (fi) Sekretion av hirudinderivat.
DE69330428D1 (de) Verbesserter wachsfreier feuchtigkeitsarmer kaugummi
FI920370L (fi) Foerfarande foer i vatten utfoerd minskning av partikelstorleken i cellulosa.
DE69221994D1 (de) Härtbare, gefüllte Polysiloxanzusammensetzungen
DE3852599D1 (de) Orale Zusammensetzungen.
FI923385L (fi) Foerfarande foer framstaellning av en oral farmaceutisk sammansaettning som innehaoller cyklosporin.
NO920234D0 (no) Helleformulering for paafoering av anthelmintika
FI922697A0 (fi) Komposition foer avlaegsnande av polymerbelaeggningar.
DE59204210D1 (de) Zahnärztliches handstück.
NO924385L (no) Preparat for oral langtidsbehandling av astma
FI20021489L (fi) Tulitikunpääformulaatioita
IT9029565U1 (it) Respiratore antigas orale.
IT9040442A1 (it) Respiratore antigas orale.
NO923593L (no) Fremgangsmaate til fremstilling av 5-amino-1-(hydroksymetyl)cyklopentan-1,2,3,4-tetraol
FI910294A7 (fi) Papper foer laeggspel.
NO913374D0 (no) Lekestativ.

Legal Events

Date Code Title Description
MK1K Patent expired